Evaluation of reading vision after cataract surgery and lens implantation

ISRCTN ISRCTN44390838
DOI https://doi.org/10.1186/ISRCTN44390838
Protocol serial number N/A
Sponsor Guy's and St Thomas' NHS Foundation Trust (UK)
Funders Guy's and St Thomas' NHS Foundation Trust (UK) - Cataract and IOL Research Fund, Fight for Sight (UK), Bausch and Lomb (USA) - providing the lenses
Submission date
09/10/2009
Registration date
26/10/2009
Last edited
04/08/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr David Spalton
Scientific

St Thomas' Hospital
Westminster Bridge Road
London
SE1 7EH
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleComparison of near vision performance of the Crystalens® HD against the Technis® Aspheric Intra-Ocular Lens: a randomised controlled trial
Study objectivesThe Crystalens® HD is a new accommodative intra-ocular lens (IOL) which may potentially improve reading and near vision compared to standard monofocal lenses. The performance of this IOL will be compared to a standard monofocal IOL.
Ethics approval(s)Guys' Hospital Research Ethics Committee, London, 08/10/2009, ref: 09/H804/82
Health condition(s) or problem(s) studiedCataracts/near vision/intra-ocular lens
InterventionCrystalens® HD vs standard monofocal IOL

Participants and outcome assessors will be blinded to participant allocation.
Intervention typeOther
Primary outcome measure(s)

Visual acuity

All primary and seconadry outcomes will be assessed at 1, 3, 6, 12 and 24 months.

Key secondary outcome measure(s)

1. Refraction
2. Objective optical image quality
3. Posterior capsule opacification
4. Measurement of IOL position
5. Contrast sensitivity
6. Objective and subjective measure of accommodation
7. Pupil size

All primary and seconadry outcomes will be assessed at 1, 3, 6, 12 and 24 months.

Completion date20/11/2011

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration80
Key inclusion criteria1. Both males and females, aged 18 years or older
2. Documented diagnosis of bilateral cataract requiring surgery
3. Potential visual acuity of 6/12 or better in both eyes
4. Patients who require an IOL in the range of 10-30 dioptres
5. Corneal astigmatism less than/equal to 1.0 dioptres after cataract surgery
6. Patients willing and able to provide informed consent and able to attend follow-up appointments
Key exclusion criteria1. Any coexisting ocular disease
2. Treatment with any ocular medication apart from artificial tear drops
3. Patients who are not fluent in English
4. Females of childbearing potential who are currently pregnant or breastfeeding
Date of first enrolment20/11/2009
Date of final enrolment20/11/2011

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

St Thomas' Hospital
London
SE1 7EH
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/12/2013 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes